You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 6, March 27, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Medical Practice, Other
 •Lipids and Lipid Disorders
 •Quality of Care, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Quality Improvement on Racial Disparities in Diabetes Care

Thomas D. Sequist, MD, MPH; Alyce Adams, PhD; Fang Zhang, MS; Dennis Ross-Degnan, ScD; John Z. Ayanian, MD, MPP

Arch Intern Med. 2006;166:675-681.

Background  Racial disparities in care are well documented; information regarding solutions is limited. We evaluated whether generic quality improvement efforts were associated with changes in racial disparities in diabetes care.

Methods  Using insurance claims and electronic medical record data, we identified 5101 whites and 1987 blacks with diabetes mellitus receiving care within a multispecialty group practice from 1997 to 2001. We assessed rates of annual low-density lipoprotein cholesterol level testing, low-density lipoprotein cholesterol level control (<130 mg/dL [<3.37 mmol/L]), statin therapy, annual glycosylated hemoglobin level testing, glycosylated hemoglobin level control (<7.0%), and annual dilated eye examinations. We used logistic regression models with generalized estimating equations to adjust for race, year, race x year interactions, age, and sex.

Results  Rates of annual low-density lipoprotein cholesterol level testing increased from 39% to 64%, while the white-black disparity decreased from 14% to 4%; rates of low-density lipoprotein cholesterol level control increased from 15% to 43%, while the white-black disparity decreased from 9% to 6% (P<.001 for both race x year interactions). Statin therapy rates increased from 20% to 37%; however, black patients remained less likely than white patients to receive therapy. The 1997 rates of annual glycosylated hemoglobin level testing (76%) and annual eye examinations (74%) were high, and there was no white-black disparity over time. Rates of glycosylated hemoglobin level control remained low (31%), and the white-black disparity remained constant at 10%.

Conclusions  Racial disparities were diminished in some aspects of diabetes care following variably successful quality improvement, but differences in the use of statins and glycemic level control persisted. Reducing disparities may require a focus on minority health.


Author Affiliations: Departments of Health Care Policy (Drs Sequist and Ayanian) and Ambulatory Care and Prevention (Drs Adams and Ross-Degnan and Mr Zhang), Harvard Medical School; Division of General Medicine and Primary Care, Brigham and Women's Hospital (Drs Sequist and Ayanian); Harvard Vanguard Medical Associates (Dr Sequist); and Harvard Pilgrim Health Care (Drs Adams and Ross-Degnan and Mr Zhang); Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Use of Electronic Medical Records for Health Outcomes Research: A Literature Review
Dean et al.
Med Care Res Rev 2009;66:611-638.
ABSTRACT  

Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage
McWilliams et al.
ANN INTERN MED 2009;150:505-515.
ABSTRACT | FULL TEXT  

Impact of Pay for Performance on Ethnic Disparities in Intermediate Outcomes for Diabetes: A Longitudinal Study
Millett et al.
Diabetes Care 2009;32:404-409.
ABSTRACT | FULL TEXT  

Death Toll From Uncontrolled Blood Pressure in Ethnic Populations: Universal Access and Quality Improvement May Not Be Enough
Cene and Cooper
Ann Fam Med 2008;6:486-489.
FULL TEXT  

Physician Performance and Racial Disparities in Diabetes Mellitus Care
Sequist et al.
Arch Intern Med 2008;168:1145-1151.
ABSTRACT | FULL TEXT  

Medication Adherence and Racial Differences in A1C Control
Adams et al.
Diabetes Care 2008;31:916-921.
ABSTRACT | FULL TEXT  

Trends in A1C Concentrations Among U.S. Adults With Diagnosed Diabetes From 1999 to 2004
Ford et al.
Diabetes Care 2008;31:102-104.
FULL TEXT  

Socio-economic status, ethnicity and diabetes management: an analysis of time trends using the health survey for England
Millett et al.
J Public Health (Oxf) 2007;29:413-419.
ABSTRACT | FULL TEXT  

Invited Commentary: Untangling the Web of Diabetes Causality in African Americans
Grant
Am J Epidemiol 2007;166:388-390.
ABSTRACT | FULL TEXT  

Back to the Future? Diabetes, HIV, and the Boundaries of Public Health
Fairchild and Alkon
Journal of Health Politics, Policy and Law 2007;32:561-593.
ABSTRACT  

Missed opportunities in the primary care management of early acute ischemic heart disease.
Sequist et al.
Arch Intern Med 2006;166:2237-2243.
ABSTRACT | FULL TEXT  

Relationship between quality of care and racial disparities in medicare health plans.
Trivedi et al.
JAMA 2006;296:1998-2004.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.